The document contains information on 438 pharmaceutical products including their identification numbers, years of approval or publication, whether intended for human or veterinary use, and classification as a generic, new chemical entity, biological, or other. The products span the years 1990 to 2018 and include both small molecule drugs and biologicals.
Revisions To Interpretive Guidelines For Centers For Medicare & Medicaid Services Hospital Conditions of Participation 42 CFR 482.12, 482.13, 482.27 and 482.28
The document contains information on 438 pharmaceutical products including their identification numbers, years of approval or publication, whether intended for human or veterinary use, and classification as a generic, new chemical entity, biological, or other. The products span the years 1990 to 2018 and include both small molecule drugs and biologicals.
The document contains information on 438 pharmaceutical products including their identification numbers, years of approval or publication, whether intended for human or veterinary use, and classification as a generic, new chemical entity, biological, or other. The products span the years 1990 to 2018 and include both small molecule drugs and biologicals.
The document contains information on 438 pharmaceutical products including their identification numbers, years of approval or publication, whether intended for human or veterinary use, and classification as a generic, new chemical entity, biological, or other. The products span the years 1990 to 2018 and include both small molecule drugs and biologicals.
Revisions To Interpretive Guidelines For Centers For Medicare & Medicaid Services Hospital Conditions of Participation 42 CFR 482.12, 482.13, 482.27 and 482.28